▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁still 6.71875
▁considered 3.98828125
▁to 1.927734375
▁be 0.032806396484375
▁an 2.6796875
▁extreme 7.26171875
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.15576171875
▁ 0.390380859375
8 3.47265625
% 2.19140625
▁of 0.122314453125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.319580078125
▁countries 0.91650390625
. 0.63525390625
▁The 2.115234375
▁introduction 7.74609375
▁of 0.0309906005859375
▁the 2.357421875
▁study 7.31640625
▁describes 7.28515625
▁the 0.5732421875
▁apparent 8.9140625
▁link 4.6796875
▁between 0.2406005859375
▁pain 2.71875
▁and 0.2958984375
▁dem 7.14453125
oral 3.390625
ization 0.12353515625
. 1.046875
▁The 1.3984375
▁research 2.39453125
▁investig 5.27734375
ates 0.4638671875
▁the 0.3505859375
▁development 6.484375
▁of 0.170654296875
▁de 3.53515625
pression 0.36328125
▁and 1.49609375
▁anx 1.8193359375
iety 0.0015811920166015625
▁among 1.4912109375
▁patients 1.5654296875
▁receiving 5.14453125
▁ph 5.83203125
arma 2.677734375
ce 0.0078125
ut 0.0001710653305053711
ical 0.00873565673828125
▁op 3.966796875
io 0.103271484375
ids 0.392578125
▁and 2.728515625
▁medical 4.1171875
▁mar 1.7138671875
iju 0.0020313262939453125
ana 6.639957427978516e-05
▁( 2.88671875
MM 0.99462890625
) 2.845703125
▁as 2.73046875
▁severe 9.9296875
▁pain 0.720703125
kill 3.025390625
ers 0.0006136894226074219
. 0.2183837890625
▁Chron 5.3046875
ic 0.002895355224609375
▁pain 0.1904296875
▁is 1.064453125
▁always 5.80859375
▁accompanied 3.248046875
▁by 0.06298828125
▁negative 4.4375
▁emot 0.91748046875
ional 1.19140625
▁experiences 2.775390625
▁and 2.001953125
▁blocks 11.3984375
▁a 3.203125
▁person 0.806640625
’ 0.6962890625
s 0.001041412353515625
▁ability 1.3935546875
▁to 0.0247955322265625
▁receive 6.5625
▁joy 3.8828125
▁and 1.365234375
▁satisfaction 3.052734375
▁from 0.83544921875
▁life 0.74609375
. 0.2080078125
▁It 3.21875
▁comp 7.23828125
ares 4.6171875
▁the 0.69970703125
▁effic 4.34765625
acy 0.0021686553955078125
▁of 0.1578369140625
▁pres 5.75
cri 2.35546875
ptions 1.6845703125
▁and 2.130859375
▁exam 5.58203125
ines 0.034912109375
▁the 0.472412109375
▁possibility 4.21484375
▁of 0.0740966796875
▁post 8.34375
- 0.580078125
tre 2.291015625
at 0.003078460693359375
ment 0.00852203369140625
▁de 1.3818359375
pression 0.05499267578125
. 1.4296875
▁There 5.48828125
▁is 1.0029296875
▁currently 6.06640625
▁a 1.201171875
▁severe 5.078125
▁lack 1.8583984375
▁of 0.01288604736328125
▁information 2.17578125
▁about 1.3046875
▁the 0.56591796875
▁effects 3.16015625
▁of 0.06365966796875
▁op 3.205078125
i 3.427734375
ates 0.0107269287109375
. 3.275390625
▁A 4.296875
▁more 5.40625
▁manage 9.2421875
able 0.000637054443359375
▁and 2.359375
▁sa 3.162109375
fer 8.308887481689453e-05
▁alternative 1.7333984375
▁might 4.8359375
▁be 0.2039794921875
▁medical 2.14453125
▁mar 0.20654296875
iju 0.0008587837219238281
ana 0.00014674663543701172
. 0.73193359375
▁They 6.7265625
▁manage 8.6484375
▁pain 2.66796875
▁successfully 6.015625
, 1.6025390625
▁but 0.8759765625
▁the 2.234375
▁past 8.53125
▁few 2.658203125
▁dec 1.4189453125
ades 0.0003039836883544922
▁indicated 7.6015625
▁the 2.140625
▁growing 4.76953125
▁concern 2.91796875
▁regarding 2.66796875
▁op 3.048828125
iate 1.4931640625
▁ab 1.49609375
use 0.01290130615234375
▁in 3.978515625
▁forms 9.625
▁of 0.347412109375
▁over 3.412109375
d 0.1265869140625
ose 0.30810546875
▁and 0.75341796875
▁add 0.79541015625
iction 0.02093505859375
. 0.108154296875
▁However 4.15234375
, 0.004119873046875
▁the 1.6435546875
▁legal 4.73828125
▁status 2.416015625
▁and 3.458984375
▁novel 9.28125
ty 0.94970703125
▁of 0.13525390625
▁this 4.40234375
▁drug 1.8671875
▁do 4.76171875
▁not 0.019500732421875
▁allow 0.80810546875
▁finding 7.0546875
▁a 2.23828125
▁large 3.4296875
▁number 0.9365234375
▁of 0.0035762786865234375
▁studies 1.478515625
▁on 1.623046875
▁its 1.302734375
▁effect 2.607421875
iveness 0.35791015625
. 0.65673828125
▁Specifically 9.1953125
, 0.04901123046875
▁it 2.64453125
▁concerns 5.58984375
▁the 0.88720703125
▁emot 6.30078125
ional 0.0192108154296875
▁condition 4.47265625
▁of 0.275634765625
▁patients 0.75830078125
▁experien 5.609375
cing 9.584426879882812e-05
▁chron 0.94873046875
ic 0.0004279613494873047
▁pain 0.062347412109375
. 0.409423828125
▁This 2.94140625
▁research 1.9931640625
▁paper 3.83203125
▁a 2.099609375
ims 0.00131988525390625
▁to 0.09466552734375
▁analyze 3.056640625
▁levels 10.25
▁of 0.025848388671875
▁de 0.5732421875
pression 0.031036376953125
▁and 0.2215576171875
▁anx 0.03387451171875
iety 0.00044608116149902344
▁among 0.7890625
▁people 2.53515625
▁receiving 2.34765625
▁ther 6.37109375
apy 0.1005859375
▁by 4.55859375
▁comparing 7.91796875
▁the 1.5927734375
▁effects 2.154296875
▁of 0.031951904296875
▁ph 2.853515625
arma 0.035888671875
ce 0.0025768280029296875
ut 0.00017178058624267578
ical 0.0036182403564453125
▁op 0.14697265625
io 0.469482421875
ids 0.035064697265625
▁and 0.257568359375
▁MM 0.64892578125
. 0.287841796875
▁The 1.6259765625
▁study 2.0
▁was 3.35546875
▁conducted 0.72314453125
▁in 1.3154296875
▁the 1.412109375
▁form 2.755859375
▁of 0.0027313232421875
▁collection 11.515625
▁and 0.8076171875
▁analysis 0.43212890625
▁of 0.01451873779296875
▁statistical 3.732421875
▁data 0.1427001953125
. 1.2138671875
▁Part 5.52734375
icip 0.2178955078125
ants 0.0538330078125
▁were 0.80712890625
▁rec 3.876953125
ru 0.0011529922485351562
ited 4.8041343688964844e-05
▁for 4.2109375
▁six 6.82421875
▁months 0.3544921875
▁at 4.109375
▁two 2.701171875
▁major 4.16015625
▁pain 2.802734375
▁relief 3.986328125
▁cent 0.8173828125
ers 0.037689208984375
▁in 0.67333984375
▁Israel 4.86328125
. 0.3154296875
▁To 5.16796875
▁specifically 10.3515625
▁evaluate 3.373046875
▁and 4.98046875
▁compare 0.79248046875
▁the 0.42138671875
▁prob 9.6875
abilities 0.0692138671875
▁of 0.08538818359375
▁de 0.9140625
pression 0.046142578125
▁or 4.37890625
▁anx 0.0694580078125
iety 0.0006551742553710938
▁among 1.6396484375
▁the 1.873046875
▁diverse 9.390625
▁groups 0.93017578125
, 0.68115234375
▁the 0.8154296875
▁study 2.498046875
▁used 1.267578125
▁multiple 5.59765625
▁log 1.4609375
istic 0.0291900634765625
▁regression 0.297607421875
▁analysis 1.435546875
▁and 2.720703125
▁chose 8.6875
▁medical 5.47265625
▁mar 0.138671875
iju 0.0012369155883789062
ana 6.663799285888672e-05
▁as 0.55029296875
▁the 0.94775390625
▁control 2.69921875
▁group 0.61962890625
. 0.2042236328125
▁The 0.80322265625
▁research 2.248046875
ers 2.140625
▁used 2.919921875
▁The 7.12890625
▁De 2.87890625
pression 0.021820068359375
▁Module 6.34765625
▁of 0.94580078125
▁the 0.258056640625
▁Pat 3.19921875
ient 0.00994873046875
▁Health 0.0323486328125
▁Question 0.0191802978515625
naire 0.02691650390625
▁and 2.361328125
▁the 0.82421875
▁General 1.1064453125
ized 0.57275390625
▁An 0.005939483642578125
x 9.334087371826172e-05
iety 0.0006380081176757812
▁Dis 0.218994140625
order 0.0222930908203125
▁Sc 1.412109375
ale 0.00341796875
▁to 1.0732421875
▁interview 8.0703125
▁participants 2.02734375
, 4.19140625
▁evaluate 4.5703125
▁their 0.8017578125
▁answers 3.310546875
, 0.302734375
▁and 0.039825439453125
▁conduct 4.234375
▁the 1.46484375
▁study 2.505859375
. 0.094482421875
▁All 5.3515625
▁tools 7.125
▁in 5.23046875
▁the 0.467529296875
▁form 5.14453125
▁of 0.04156494140625
▁question 0.80908203125
na 0.01019287109375
ires 9.381771087646484e-05
▁and 2.462890625
▁scales 2.77734375
▁have 3.158203125
▁already 3.455078125
▁been 0.355224609375
▁used 2.4921875
▁and 2.015625
▁proved 2.400390625
▁their 1.5595703125
▁effic 2.67578125
acy 0.002841949462890625
▁for 3.408203125
▁collect 4.140625
ing 0.00431060791015625
▁analyt 7.51953125
ical 0.09197998046875
▁data 0.21630859375
. 0.468017578125
▁This 3.40234375
▁type 4.74609375
▁of 0.003910064697265625
▁study 1.85546875
▁is 1.2841796875
▁the 3.71484375
▁most 1.10546875
▁reve 8.765625
aling 0.0011005401611328125
▁and 1.2333984375
▁inclus 7.25
ive 0.001140594482421875
, 2.529296875
▁as 1.23828125
▁it 0.344970703125
▁contains 4.7421875
▁direct 5.6328125
▁responses 4.515625
▁from 0.79931640625
▁a 3.83203125
▁large 1.216796875
▁number 0.496826171875
▁of 0.00231170654296875
▁participants 1.2109375
. 0.61962890625
▁It 2.642578125
▁helps 3.671875
▁to 0.59375
▁system 7.48828125
at 0.45556640625
ize 0.0017232894897460938
▁and 1.2080078125
▁class 4.93359375
ify 0.0016384124755859375
▁distinct 7.97265625
▁kinds 6.73046875
▁of 0.0201416015625
▁information 2.6953125
▁for 4.25
▁subsequent 5.02734375
▁un 8.6640625
comp 4.36328125
licated 0.032470703125
▁services 12.3359375
. 0.6806640625
▁The 0.96044921875
▁analysis 3.712890625
▁of 1.01953125
▁any 8.71875
▁human 6.75390625
▁reaction 4.11328125
▁has 4.7421875
▁a 1.810546875
▁high 2.833984375
▁potential 3.24609375
▁of 2.48046875
▁subject 4.37109375
iveness 3.708984375
▁and 1.212890625
▁bias 2.19140625
, 1.5048828125
▁especially 3.03125
▁regarding 3.732421875
▁people 4.92578125
▁in 3.58984375
▁severe 2.4765625
▁pain 0.54443359375
▁and 2.513671875
▁un 5.66015625
stable 1.166015625
▁emot 0.78564453125
ional 0.0604248046875
▁condition 1.78515625
. 0.06768798828125
▁Thus 3.490234375
, 0.01337432861328125
▁research 4.1640625
ers 0.22509765625
▁can 3.72265625
▁compare 4.81640625
▁the 0.87548828125
▁effects 3.146484375
▁of 0.11309814453125
▁medic 3.80078125
ations 0.75634765625
▁on 1.6162109375
▁patients 2.505859375
▁of 3.77734375
▁diverse 3.50390625
▁age 2.01953125
▁groups 2.52734375
, 0.66943359375
▁background 4.17578125
s 0.18505859375
, 0.01715087890625
▁physical 5.36328125
▁conditions 1.6181640625
, 0.04205322265625
▁emot 5.80078125
ional 0.035614013671875
▁states 1.5078125
, 0.0457763671875
▁and 0.33544921875
▁so 3.123046875
▁on 0.3564453125
. 0.11102294921875
▁Perhaps 9.5703125
▁some 5.44140625
▁patients 3.595703125
▁tend 5.48828125
▁to 0.007781982421875
▁ex 2.65625
agger 0.01100921630859375
ate 0.0018768310546875
▁their 0.978515625
▁de 3.521484375
press 1.615234375
ive 0.05743408203125
▁state 2.654296875
▁or 1.7294921875
▁vice 5.24609375
▁vers 0.0203704833984375
a 3.1948089599609375e-05
, 0.97119140625
▁de 7.546875
- 2.44140625
emph 0.476318359375
as 0.0023097991943359375
ize 0.0487060546875
▁serious 6.62109375
▁difficulties 5.8203125
. 0.7626953125
▁Because 6.6875
▁the 2.37109375
▁survey 4.86328125
▁responses 6.77734375
▁were 1.59765625
▁thoroughly 8.1640625
▁anonymous 2.84375
, 0.260986328125
▁the 1.2744140625
▁research 1.1669921875
ers 0.1983642578125
▁were 2.32421875
▁unable 3.10546875
▁to 0.0013980865478515625
▁carefully 8.2265625
▁analyze 2.580078125
▁each 2.455078125
▁patient 2.30859375
’ 0.4921875
s 0.0010061264038085938
▁reaction 3.720703125
▁and 1.453125
▁compare 3.83984375
▁it 0.85546875
▁to 0.5185546875
▁the 1.0078125
▁actual 4.44921875
▁states 7.8671875
▁of 0.669921875
▁condition 7.0703125
. 0.35595703125
▁However 2.49609375
, 0.0005679130554199219
▁this 2.076171875
▁method 3.080078125
▁of 1.646484375
▁research 2.482421875
▁is 1.259765625
▁way 8.9921875
▁more 0.22509765625
▁resource 7.30078125
- 2.138671875
int 2.28125
ensive 0.01413726806640625
▁and 0.701171875
▁energy 11.3046875
- 0.054718017578125
consum 0.6376953125
ing 0.0022487640380859375
. 1.77734375
▁Part 5.59765625
icip 0.2491455078125
ants 0.0999755859375
▁were 2.14453125
▁rec 2.537109375
ru 0.0006303787231445312
ited 2.110004425048828e-05
▁for 1.8193359375
▁six 0.331298828125
▁months 0.006374359130859375
▁at 0.441162109375
▁two 0.0723876953125
▁major 0.10845947265625
▁pain 0.038787841796875
▁relief 0.0285491943359375
▁cent 0.014678955078125
ers 0.0010843276977539062
▁in 0.051239013671875
▁Israel 0.01300048828125
. 0.197998046875
▁More 6.1328125
▁accurate 5.66796875
▁answers 4.26953125
▁could 2.61328125
▁be 0.414794921875
▁obtained 0.99267578125
▁by 1.5634765625
▁professional 6.23046875
▁psych 1.333984375
olog 0.254150390625
ists 0.0005092620849609375
▁via 7.09765625
▁personal 2.658203125
▁communication 3.94921875
▁and 1.8271484375
▁behavior 6.4140625
al 0.221435546875
▁analysis 1.9990234375
. 0.279052734375
▁All 4.7109375
▁patients 3.056640625
▁experienced 4.84765625
▁chron 0.8876953125
ic 0.0001811981201171875
▁pain 0.11297607421875
▁for 2.814453125
▁at 0.69873046875
▁least 0.0010585784912109375
▁ 1.8837890625
3 1.6318359375
▁months 0.379150390625
. 1.24609375
▁The 1.404296875
▁study 1.640625
▁included 2.17578125
▁ 0.6806640625
8 3.01171875
9 2.55078125
0 3.044921875
▁participants 1.5087890625
, 1.4052734375
▁of 2.677734375
▁which 0.434326171875
▁ 0.1083984375
4 1.1806640625
7 2.669921875
4 2.62109375
▁( 3.05078125
5 0.09539794921875
9 4.72265625
%) 0.81884765625
▁were 0.76904296875
▁treated 3.228515625
▁sole 6.58984375
ly 7.68899917602539e-05
▁with 0.287109375
▁op 1.42578125
io 0.385986328125
ids 0.12548828125
, 0.51318359375
▁ 0.810546875
3 1.267578125
2 2.23046875
9 2.478515625
▁( 0.049102783203125
4 2.46875
1 1.1533203125
%) 0.0625
▁were 1.4345703125
▁treated 0.52001953125
▁with 0.405517578125
▁MM 0.6220703125
, 0.37548828125
▁and 0.10455322265625
▁ 0.2220458984375
7 2.095703125
7 2.34765625
▁( 0.109619140625
8 1.9443359375
. 0.931640625
6 2.4140625
%) 0.0797119140625
▁acquired 10.5625
▁both 0.62109375
▁( 4.6171875
Fe 9.2734375
ing 1.4482421875
old 0.314697265625
▁et 1.001953125
▁al 0.021484375
., 0.175537109375
▁ 0.0127410888671875
2 0.0081939697265625
0 0.0002753734588623047
1 0.36962890625
7 1.751953125
). 0.04461669921875
▁The 1.03515625
▁remaining 7.328125
▁ten 6.75390625
▁participants 1.5263671875
▁who 4.98046875
▁did 2.306640625
▁not 0.006259918212890625
▁receive 2.296875
▁ph 3.998046875
arma 0.10308837890625
ce 0.0007715225219726562
ut 5.602836608886719e-06
ical 0.0022640228271484375
▁op 1.427734375
io 0.049407958984375
ids 0.0261688232421875
▁and 2.49609375
▁medical 1.6123046875
▁mar 0.040130615234375
iju 0.00028014183044433594
ana 4.971027374267578e-05
▁were 0.51171875
▁with 6.6328125
dra 0.0579833984375
wn 4.0411949157714844e-05
▁from 0.276123046875
▁the 0.1982421875
▁analysis 2.287109375
▁in 5.12109375
▁the 1.1611328125
▁research 4.28125
. 1.0302734375
▁Therefore 4.7421875
, 0.0147705078125
▁it 3.43359375
▁is 1.0791015625
▁not 2.779296875
▁possible 0.8115234375
▁to 0.00775146484375
▁compreh 5.78125
ens 0.14306640625
ively 0.0162506103515625
▁compare 1.5556640625
▁patients 4.875
▁taking 3.72265625
▁medic 4.046875
ations 0.52783203125
▁with 1.4658203125
▁those 1.2353515625
▁who 0.75048828125
▁do 1.3662109375
▁not 0.004962921142578125
. 0.6298828125
▁It 2.94921875
▁evaluated 12.2265625
▁the 0.59912109375
▁inter 6.7109375
dep 3.123046875
end 0.00023365020751953125
ence 0.0050201416015625
▁of 0.47216796875
▁various 3.869140625
▁factors 0.69091796875
▁that 2.365234375
▁affected 4.5859375
▁the 0.43310546875
▁physical 6.53515625
▁and 0.3701171875
▁emot 0.53857421875
ional 0.00010764598846435547
▁condition 1.4150390625
▁of 0.11590576171875
▁patients 0.8544921875
▁experien 3.62890625
cing 4.5299530029296875e-06
▁chron 0.309326171875
ic 0.0001742839813232422
▁pain 0.0147857666015625
. 0.192138671875
▁For 3.884765625
▁example 0.8271484375
, 0.0022449493408203125
▁the 1.44921875
▁survey 5.6640625
▁showed 3.52734375
▁that 0.285400390625
▁the 2.080078125
▁ratio 6.60546875
▁of 0.06787109375
▁female 2.76171875
▁patients 0.9033203125
▁was 1.171875
▁remark 8.21875
ably 0.00018906593322753906
▁higher 0.188720703125
▁in 2.5
▁the 0.484375
▁op 3.552734375
i 3.48828125
ates 0.013519287109375
▁group 0.1837158203125
▁compared 2.6328125
▁to 0.0435791015625
▁the 0.6298828125
▁MM 0.166015625
▁group 0.32763671875
. 0.431640625
▁The 1.8896484375
▁study 2.412109375
▁conducted 4.71484375
▁a 1.8984375
▁correlation 5.2734375
▁type 9.65625
▁of 0.20556640625
▁research 1.236328125
▁with 3.66015625
▁variable 8.1484375
▁measures 5.58203125
. 0.98779296875
▁In 3.6328125
▁turn 5.44140625
, 0.0014820098876953125
▁people 6.9375
▁on 5.26171875
▁op 1.2958984375
i 0.6376953125
ates 0.0017576217651367188
▁were 1.57421875
▁more 1.0576171875
▁likely 0.328369140625
▁to 0.03118896484375
▁report 3.0625
▁major 6.04296875
▁de 0.3388671875
press 0.71875
ive 0.002346038818359375
▁dis 0.94921875
orders 1.466796875
. 1.9580078125
▁For 4.65234375
▁example 0.888671875
, 0.0018444061279296875
▁it 3.732421875
▁included 3.671875
▁compreh 10.59375
ensive 0.07867431640625
▁so 6.359375
cio 0.00176239013671875
- 0.4453125
dem 0.467041015625
ographic 0.06585693359375
▁data 1.1240234375
: 4.890625
▁gender 2.0234375
, 0.053192138671875
▁age 0.362548828125
, 0.03887939453125
▁country 4.55859375
, 2.66015625
▁type 4.296875
▁of 0.08087158203125
▁residence 4.24609375
▁( 2.580078125
urban 0.6552734375
/ 1.482421875
r 0.158203125
ural 0.0009207725524902344
), 0.1519775390625
▁years 6.25390625
▁of 0.17529296875
▁education 0.8349609375
, 0.0843505859375
▁and 1.529296875
▁employ 2.6640625
ment 0.001735687255859375
▁status 0.66015625
. 0.2381591796875
▁The 1.4873046875
▁question 4.734375
na 0.85205078125
ires 0.00013363361358642578
▁used 2.748046875
▁different 5.98046875
▁variable 8.328125
▁measures 0.46435546875
▁to 2.0234375
▁collect 2.49609375
▁information 1.5810546875
. 1.8271484375
▁Pat 4.3671875
ients 0.071044921875
▁were 1.8203125
▁also 2.2890625
▁asked 0.92333984375
▁about 0.849609375
▁their 0.8134765625
▁medical 2.759765625
▁history 0.46240234375
▁over 8.1875
▁the 0.06561279296875
▁years 4.5078125
▁and 1.65625
▁the 1.5419921875
▁current 3.48828125
▁presence 4.96484375
▁of 0.0833740234375
▁any 1.955078125
▁severe 3.732421875
▁dise 1.865234375
ases 9.369850158691406e-05
▁such 4.390625
▁as 0.0012636184692382812
▁heart 2.568359375
▁failure 1.8349609375
, 0.322509765625
▁di 1.6083984375
ab 0.0007696151733398438
etes 0.0025997161865234375
, 0.07281494140625
▁ar 4.09765625
th 0.1571044921875
rit 0.0236663818359375
is 0.00411224365234375
, 0.025360107421875
▁and 1.1875
▁so 0.708984375
▁on 0.052734375
. 0.052734375
▁The 1.486328125
▁third 7.34765625
▁measure 3.78515625
▁of 2.2109375
▁the 0.68408203125
▁question 3.73046875
naire 0.301513671875
▁was 1.236328125
▁indicated 10.609375
▁by 1.181640625
▁information 6.92578125
▁on 1.9287109375
▁any 4.80078125
▁twelve 14.140625
- 0.2177734375
month 0.18505859375
▁and 4.953125
▁lifetime 0.68017578125
▁drug 3.302734375
▁and 1.69921875
▁alco 0.143798828125
hol 7.557868957519531e-05
▁consumption 4.62890625
. 0.43212890625
▁In 3.154296875
▁addition 1.384765625
, 0.204833984375
▁the 0.9716796875
▁record 10.1171875
▁included 1.5810546875
▁a 2.744140625
▁pain 5.34765625
▁measurement 4.96875
▁scale 0.8359375
▁from 4.32421875
▁ 0.5634765625
0 0.3134765625
▁to 0.2222900390625
▁ 0.00731658935546875
1 0.07135009765625
0 0.0343017578125
▁to 3.185546875
▁evaluate 1.5205078125
▁dis 6.203125
com 0.1497802734375
fort 0.002368927001953125
▁feelings 8.28125
▁during 4.265625
▁the 0.3134765625
▁last 1.107421875
▁month 1.7158203125
. 0.2325439453125
▁Among 5.765625
▁all 2.28515625
▁participants 1.9873046875
▁in 3.7109375
▁the 0.228271484375
▁study 0.703125
, 0.050140380859375
▁ 0.80322265625
4 1.916015625
2 2.326171875
. 1.2216796875
2 2.216796875
% 0.06427001953125
▁suffered 3.82421875
▁from 0.060394287109375
▁de 1.9365234375
pression 0.2469482421875
, 0.8740234375
▁and 1.1630859375
▁ 0.139404296875
3 1.44921875
7 2.35546875
% 2.638671875
▁experienced 2.048828125
▁excess 6.67578125
ive 0.0250396728515625
▁anx 0.2347412109375
iety 0.0016956329345703125
. 0.43408203125
▁The 1.470703125
▁pl 10.953125
ur 0.953125
ality 0.0018625259399414062
▁of 0.1290283203125
▁de 2.615234375
press 1.2666015625
ive 0.026611328125
▁dis 2.048828125
orders 0.07794189453125
▁among 2.884765625
▁patients 0.95849609375
▁in 2.884765625
▁the 0.29052734375
▁op 0.55322265625
i 0.421630859375
ates 0.0016908645629882812
, 9.171875
▁medical 4.12109375
▁mar 0.031646728515625
iju 0.0006165504455566406
ana 2.5033950805664062e-05
, 0.2294921875
▁and 0.09381103515625
▁mixed 1.70703125
▁OP 11.3046875
MM 4.3515625
▁groups 0.576171875
▁number 9.1953125
ed 0.0214385986328125
▁ 0.150634765625
5 1.7705078125
7 2.62109375
. 0.46484375
1 2.548828125
%, 0.2132568359375
▁ 0.00417327880859375
2 1.9599609375
2 2.658203125
. 0.1031494140625
3 2.271484375
%, 0.05377197265625
▁and 0.05584716796875
▁ 0.002071380615234375
5 2.1484375
1 2.08984375
. 0.159912109375
4 1.89453125
%, 0.145751953125
▁respectively 0.0162200927734375
. 0.28076171875
▁The 1.2548828125
▁pl 4.09375
ur 0.007778167724609375
ality 4.863739013671875e-05
▁of 0.025054931640625
▁anx 0.4833984375
iety 0.01404571533203125
▁contained 10.65625
▁ 0.231201171875
4 1.12890625
8 2.380859375
. 0.1661376953125
4 2.20703125
% 2.064453125
▁among 2.423828125
▁OP 5.2578125
▁patients 5.84375
, 0.283203125
▁ 0.09375
2 0.923828125
1 2.462890625
. 0.10675048828125
5 2.115234375
% 0.026397705078125
▁among 0.455322265625
▁MM 0.11328125
▁patients 0.35791015625
, 0.020111083984375
▁and 0.01534271240234375
▁ 0.02752685546875
3 1.4189453125
8 1.9130859375
. 0.1298828125
7 2.212890625
% 0.01323699951171875
▁among 0.1876220703125
▁OP 2.00390625
MM 0.1468505859375
▁participants 3.46875
. 0.2481689453125
▁Pat 4.5234375
ients 0.0170440673828125
▁who 1.9443359375
▁took 2.2265625
▁strong 9.625
▁op 0.7294921875
i 0.78466796875
ates 0.0029850006103515625
▁were 1.1982421875
▁t 10.1796875
ended 1.044921875
▁to 0.008087158203125
▁place 9.921875
▁their 2.046875
▁pain 1.0927734375
▁on 1.8828125
▁a 0.58251953125
▁scale 1.6796875
▁of 0.365966796875
▁ 0.1268310546875
9 2.455078125
▁to 2.171875
▁ 0.01218414306640625
1 0.005092620849609375
0 0.005649566650390625
▁( 2.72265625
Fe 1.5341796875
ing 0.002376556396484375
old 0.0004086494445800781
▁et 0.0167083740234375
▁al 0.0014476776123046875
., 0.010406494140625
▁ 0.0016145706176757812
2 0.00016021728515625
0 2.753734588623047e-05
1 0.0020389556884765625
7 0.007503509521484375
). 0.010711669921875
▁They 3.2109375
▁were 1.7705078125
▁also 1.3623046875
▁an 9.34375
gu 4.8125
ished 0.0733642578125
▁em 6.234375
otion 0.0008916854858398438
ally 0.0007829666137695312
▁and 1.1435546875
▁react 7.20703125
ed 0.02496337890625
▁rad 8.984375
ically 0.0008134841918945312
▁neg 4.80078125
atively 0.0011987686157226562
▁to 0.2183837890625
▁almost 5.32421875
▁all 1.521484375
▁survey 3.8125
▁questions 0.2374267578125
. 0.3125
▁Pat 2.927734375
ients 0.005947113037109375
▁who 1.1728515625
▁took 1.6435546875
▁only 4.484375
▁MM 0.378173828125
▁or 3.109375
▁mixed 2.443359375
▁medic 1.5595703125
ations 0.209716796875
▁course 13.625
▁had 2.486328125
▁a 1.302734375
▁significantly 2.810546875
▁more 3.5234375
▁stable 2.6171875
▁emot 0.8525390625
ional 0.0008406639099121094
▁state 0.533203125
▁and 1.279296875
▁cop 6.703125
ed 0.0284881591796875
▁with 0.348876953125
▁pain 1.0029296875
▁more 1.88671875
▁manage 6.90234375
able 1.4306640625
. 0.28564453125
▁One 5.5234375
▁of 0.44775390625
▁the 0.010833740234375
▁major 2.9609375
▁limitations 3.009765625
▁is 3.001953125
▁the 0.599609375
▁ins 4.609375
u 0.07049560546875
fficient 0.098876953125
ly 3.490234375
▁high 2.9765625
▁response 3.09765625
▁rate 0.10296630859375
, 2.419921875
▁ 4.5078125
5 1.685546875
7 2.673828125
% 2.208984375
▁instead 6.05078125
▁of 0.0027065277099609375
▁ 0.48291015625
7 1.794921875
0 0.452392578125
% 1.52734375
▁( 2.203125
Fe 0.6357421875
ing 0.0015821456909179688
old 0.0002732276916503906
▁et 0.01140594482421875
▁al 0.0006518363952636719
., 0.00682830810546875
▁ 0.001262664794921875
2 9.202957153320312e-05
0 8.52346420288086e-05
1 0.0003867149353027344
7 0.00257110595703125
). 0.01090240478515625
▁It 1.9521484375
▁can 3.158203125
▁be 0.7158203125
▁fairly 8.2109375
▁explained 1.9873046875
▁by 0.2113037109375
▁the 0.307373046875
▁weak 7.24609375
▁focus 7.1640625
▁of 0.72314453125
▁respond 5.44921875
ents 0.09271240234375
▁who 3.53515625
▁have 3.646484375
▁overcome 8.078125
▁severe 2.134765625
▁pain 0.5595703125
▁sens 7.54296875
ations 0.1767578125
▁and 0.96142578125
▁de 4.69140625
press 0.810546875
ive 0.0428466796875
▁episodes 2.423828125
. 0.443359375
▁It 2.669921875
▁is 0.91162109375
▁not 2.55078125
▁clear 3.296875
▁how 1.9130859375
▁to 3.162109375
▁use 4.5078125
▁these 2.580078125
▁statistics 4.24609375
, 3.17578125
▁as 0.716796875
▁they 1.8095703125
▁still 5.109375
▁may 5.25390625
▁be 1.134765625
▁relevant 6.203125
▁for 1.7119140625
▁the 2.0546875
▁overall 5.03125
▁analysis 2.541015625
. 0.92626953125
